Abstract
Free Water Imaging is a novel diffusion magnetic resonance (MR) imaging method that is able to separate changes affecting the extracellular space from those that reflect changes in neuronal cells and processes. A previous Free Water Imaging study in schizophrenia identified significantly greater extracellular water volume in the early stages of the disorder; however, its clinical and functional sequelae have not yet been investigated. Here, we applied Free Water Imaging to a larger cohort of 63 first-episode patients with psychosis and 70 healthy matched controls to better understand the functional significance of greater extracellular water. We used diffusion MR imaging data and the Tract-Based Spatial Statistics analytic pipeline to first analyze fractional anisotropy (FA), the most commonly employed metric for assessing white matter. This comparison was then followed by Free Water Imaging analysis, where two parameters, the fractional volume of extracellular free-water (FW) and cellular tissue FA (FA-t), were estimated and compared across the entire white matter skeleton between groups, and correlated with cognitive measures at baseline and following 12 weeks of antipsychotic treatment. Our results indicated lower FA across the whole brain in patients compared with healthy controls that overlap with significant increases in FW, with only limited decreases in FA-t. In addition, higher FW correlated with better neurocognitive functioning following 12 weeks of antipsychotic treatment. We believe this is the first study to suggest that an extracellular water increase during the first-episode of psychosis, which may be indicative of an acute neuroinflammatory process, and/or cerebral edema may predict better functional outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mueser KT, McGurk SR . Schizophrenia. Lancet 2004; 363: 2063–2072.
Friston KJ, Frith CD . Schizophrenia: a disconnection syndrome? Clin Neurosci 1995; 3: 89–97.
Friston KJ . Schizophrenia and the disconnection hypothesis. Acta Psychiatr Scand Suppl 1999; 395: 68–79.
Kochunov P, Hong LE . Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull 2014; 40: 721–728.
Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD . Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment 2011; 2011: 325789–13.
Voineskos AN, Felsky D, Kovacevic N, Tiwari AK, Zai C, Chakravarty MM et al. Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. Cereb Cortex 2013; 23: 2044–2057.
Basser PJ, Mattiello J, LeBihan D . MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259–267.
Kubicki M, McCarley R, Westin C-F, Park H-J, Maier S, Kikinis R et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res 2007; 41: 15–30.
Wheeler AL, Voineskos AN . A review of structural neuroimaging in schizophrenia: from connectivity to connectomics. Front Hum Neurosci 2014; 8: 653.
Assaf Y, Pasternak O . Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 2008; 34: 51–61.
Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y . Free water elimination and mapping from diffusion MRI. Magn Reson Med 2009; 62: 717–730.
Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargallo N et al. Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: a longitudinal multisite study of healthy elderly subjects. Hum Brain Mapp 2016; 38: 12–26.
Pasternak O, Westin C-F, Bouix S, Seidman LJ, Goldstein JM, Woo T-UW et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci 2012; 32: 17365–17372.
Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: An [(11)C]PBR28 PET brain imaging study. Am J Psychiatry 2015; 173: 44–52.
Doorduin J, de Vries EFJ, Willemsen ATM, de Groot JC, Dierckx RA, Klein HC . Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009; 50: 1801–1807.
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B . Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011; 70: 663–671.
Pasternak O, Westin C-F, Dahlben B, Bouix S, Kubicki M . The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res 2014; 161: 113–118.
Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang J-P et al. A randomized comparison of aripiprazole and risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3-month outcomes. Schizophr Bull 2015; 41: 1227–1236.
Overall JE, Gorhham DR . The Brief Psychiatric Rating Scale. Physiol Rep 1962; 10: 799–812.
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487–1505.
Jahanshad N, Kochunov PV, Sprooten E, Mandl RC, Nichols TE, Almasy L et al. Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage 2013; 81: 455–469.
Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014; 8: 153–182.
Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE . Permutation inference for the general linear model. Neuroimage 2014; 92: 381–397.
Smith SM, Nichols TE . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009; 44: 83–98.
Narayan S, Tang B, Head SR, Gilmartin TJ, Sutcliffe JG, Dean B et al. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res 2008; 1239: 235–248.
Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150–1159.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427.
Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium, International Inflammatory Bowel Disease Genetics Consortium (IIBDGC), International Inflammatory Bowel Disease Genetics Consortium IIBDGC. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci 2015; 18: 199–209.
Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE, Moreira JCF et al. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 2012; 46: 819–824.
Bentsen H, Solberg DK, Refsum H, Bøhmer T . Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells. Prostaglandins Leukot Essent Fatty Acids 2012; 87: 35–41.
Hoen WP, Lijmer JG, Duran M, Wanders RJA, van Beveren NJM, de Haan L . Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis. Psychiatry Res 2013; 207: 1–12.
Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013; 18: 206–214.
Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V . A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 2012; 69: 1205–1213.
Upthegrove R, Manzanares-Teson N, Barnes NM . Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 2014; 155: 101–108.
Petrikis P, Voulgari PV, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V . Cytokine profile in drug-naïve, first episode patients with psychosis. J Psychosom Res 2015; 79: 324–327.
Prasad KM, Upton CH, Nimgaonkar VL, Keshavan MS . Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. Schizophr Res 2015; 161: 119–125.
Bulzacka E, Boyer L, Schürhoff F, Godin O, Berna F, Brunel L et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull 2016; 42: 1290–1302.
Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R . C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 2007; 93: 261–265.
Najjar S, Pearlman DM . Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 2015; 161: 102–112.
Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 42: 115–121.
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E . Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008; 63: 801–808.
Meyer U, Schwarz MJ, Müller N . Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 2011; 132: 96–110.
Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T . Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002; 8: 101.
Lett TA, Voineskos AN, Kennedy JL, Levine B, Daskalakis ZJ . Treating working memory deficits in schizophrenia: a review of the neurobiology. Biol Psychiatry 2014; 75: 361–370.
Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM . Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res 2008; 105: 78–85.
Park S, Gooding DC . Working memory impairment as an endophenotypic marker of a schizophrenia diathesis. Schizophr Res Cogn 2014; 1: 127–136.
Joseph J, Depp C, Martin AS, Daly RE, Glorioso DK, Palmer BW et al. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res 2015; 168: 456–460.
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J, Ochoa S et al. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment 2012; 2012: 1–9.
Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y . Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 303–307.
Pasternak O, Kubicki M, Shenton ME . In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res 2016; 173: 200–212.
Rajkowska G, Selemon LD, Goldman-Rakic PS . Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55: 215–224.
Boksa P . Abnormal synaptic pruning in schizophrenia: urban myth or reality? J Psychiatry Neurosci 2012; 37: 75–77.
Acknowledgements
This work was supported in part by grants from the National Institutes of Mental Health to Dr. Lyall (5T32MH016259-35), Dr. Kubicki (R01AG042512 and R01MH102377), Dr. Pasternak (R01MH108574, R01MH074794, P41EB015902 and R01AG042512, R01MH102377), Dr. Szeszko (R01 MH076995), Dr. Robinson (R01 MH060004) and Dr. Gallego (K23 MH100264), the NSLIJ Research Institute General Clinical Research Center (M01 RR018535), an Advanced Center for Intervention and Services Research (P30 MH090590), a Center for Intervention Development and Applied Research (P50 MH080173) and NARSAD Young Investigator grants (to Dr. Szeszko and Dr. Pasternak).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
For a complete list of Dr. Fava’s disclosures, please see http://mghcme.org/faculty/faculty-detail/maurizio_fava#disclosure. Dr. Malhotra has been a consultant for Genomind, Forum Pharmaceuticals and Takeda Pharmaceuticals. The other authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Lyall, A., Pasternak, O., Robinson, D. et al. Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry 23, 701–707 (2018). https://doi.org/10.1038/mp.2017.43
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2017.43
This article is cited by
-
Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis
Neuropsychopharmacology (2024)
-
Extracellular free water elevations are associated with brain volume and maternal cytokine response in a longitudinal nonhuman primate maternal immune activation model
Molecular Psychiatry (2023)
-
Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization
Molecular Psychiatry (2023)
-
White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis
Neuropsychopharmacology (2022)
-
Opposing white matter microstructure abnormalities in 22q11.2 deletion and duplication carriers
Translational Psychiatry (2021)